Omalizumab is effective in the preseasonal treatment of seasonal allergic rhinitis

BACKGROUND: To date no study has evaluated the efficacy of preseasonal omalizumab therapy with cost effective dose and at appropriate time point compared with standard medication in seasonal allergic rhinitis (SAR) patients. METHODS: This was a prospective randomized controlled open‐label single‐cen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuan, Xi, Lin, Gao, Yunbo, Huang, Yanran, Cao, Feifei, Xiong, Wei, Wang, Chengshuo, Zhang, Luo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727318/
https://www.ncbi.nlm.nih.gov/pubmed/35024137
http://dx.doi.org/10.1002/clt2.12094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727318/
https://www.ncbi.nlm.nih.gov/pubmed/35024137
http://dx.doi.org/10.1002/clt2.12094

Ejemplares similares